Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.
暂无分享,去创建一个
Neha Kohli | Henry Daniell | H. Daniell | Neha Kohli | Sic L. Chan | Qiuhong Li | Ping Zhu | Amrisha Verma | Pollob Shil | Qiuhong Li | Amrisha Verma | Sic L Chan | Ping Zhu | Donevan R Westerveld | Alexandra C Ayache | Tuhina Prasad | Donevan R. Westerveld | Pollob Shil | Tuhina Prasad | A. Ayache
[1] Yu Fang,et al. Characterization of cholera toxin B subunit‐induced Ca2+ influx in neuroblastoma cells: Evidence for a voltage‐independent GM1 ganglioside‐associated Ca2+ channel , 2002, Journal of neuroscience research.
[2] Sean P. Palecek,et al. Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells , 2012, Nature Biotechnology.
[3] F. Bloom,et al. Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Daniell,et al. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. , 2013, Advanced drug delivery reviews.
[5] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[6] Henry Daniell,et al. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells. , 2013, Plant biotechnology journal.
[7] I. Zuhorn,et al. Peptide-mediated blood-brain barrier transport of polymersomes. , 2012, Angewandte Chemie.
[8] Gregory J Brewer,et al. Amyloid-β as a modulator of synaptic plasticity. , 2010, Journal of Alzheimer's disease : JAD.
[9] Xiaomei Wang,et al. Mechanism of oral tolerance induction to therapeutic proteins. , 2013, Advanced drug delivery reviews.
[10] Yan Luo,et al. Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium , 2011, Progress in Retinal and Eye Research.
[11] M. Tabaton,et al. The molecular link between β- and γ-secretase activity on the amyloid β precursor protein , 2007, Cellular and Molecular Life Sciences.
[12] J. Duggan,et al. Alzheimer's disease and retinal neurodegeneration. , 2009, Current Alzheimer research.
[13] D. Selkoe,et al. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[14] H. Daniell,et al. A protocol for expression of foreign genes in chloroplasts , 2008, Nature Protocols.
[15] S. Salomone,et al. Ocular drug delivery: a clue from nanotechnology , 2012, Front. Pharmacol..
[16] H. Brodaty,et al. ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.
[17] P. Tariot,et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. , 2010, Clinical therapeutics.
[18] G. Halliday,et al. Focal demyelination in Alzheimer’s disease and transgenic mouse models , 2010, Acta Neuropathologica.
[19] D. Lalloo,et al. Oral cholera vaccines: use in clinical practice. , 2006, The Lancet. Infectious diseases.
[20] Tracey A Ruhlman,et al. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice. , 2007, Plant biotechnology journal.
[21] Henry Daniell,et al. Low Cost Tuberculosis Vaccine Antigens in Capsules: Expression in Chloroplasts, Bio-Encapsulation, Stability and Functional Evaluation In Vitro , 2013, PloS one.
[22] Coleman O. Martin,et al. Neuro-ophthalmic findings in the visual variant of Alzheimer's disease. , 2004, Ophthalmology.
[23] W. V. Van Nostrand,et al. Degradation of Amyloid β Protein by Purified Myelin Basic Protein* , 2009, The Journal of Biological Chemistry.
[24] S. Janciauskiene,et al. Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease. , 2001, Acta ophthalmologica Scandinavica.
[25] J. Holmgren,et al. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects , 2008, Cellular and Molecular Life Sciences.
[26] J. Kaye,et al. Blood–brain barrier impairment in Alzheimer disease , 2007, Neurology.
[27] L. Ferrucci,et al. Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden , 2013, Neurobiology of Aging.
[28] H. E. Stanley,et al. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Janciauskiene,et al. Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome , 2003, Documenta Ophthalmologica.
[30] P. Couraud,et al. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation , 2012, Fluids and Barriers of the CNS.
[31] Judianne Davis,et al. N-terminal Domain of Myelin Basic Protein Inhibits Amyloid β-Protein Fibril Assembly* , 2010, The Journal of Biological Chemistry.
[32] W. Pardridge,et al. Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] H. Daniell,et al. Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice , 2010, Proceedings of the National Academy of Sciences.
[34] A. Mehta,et al. Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. , 2011, Blood.
[35] S. Young,et al. Drug delivery to the posterior segment of the eye. , 2011, Drug discovery today.
[36] Shuangxia Jin,et al. Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. , 2011, Plant biotechnology journal.
[37] W. V. Van Nostrand,et al. Myelin basic protein binds to and inhibits the fibrillar assembly of Abeta42 in vitro. , 2009, Biochemistry.
[38] J. Boggs,et al. Myelin basic protein: a multifunctional protein , 2006, Cellular and Molecular Life Sciences CMLS.
[39] S. Ichinose,et al. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. , 2005, The Journal of clinical investigation.
[40] Tracey A Ruhlman,et al. The Role of Heterologous Chloroplast Sequence Elements in Transgene Integration and Expression1[W][OA] , 2010, Plant Physiology.
[41] A. Sillito,et al. Targeting amyloid-β in glaucoma treatment , 2007, Proceedings of the National Academy of Sciences.
[42] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[43] Jaime Grutzendler,et al. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches , 2004, Nature Neuroscience.
[44] Xudong Huang,et al. Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease , 2003, The Lancet.
[45] B. Liu,et al. Amyloid-β Immunotherapy for Alzheimers Disease , 2010 .
[46] R. Gabathuler,et al. Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.
[47] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[48] H. Daniell,et al. Receptor‐mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] M. Mattson,et al. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model. , 2011, Journal of Alzheimer's disease : JAD.